In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Alx Oncology Holdings Inc (NASDAQ: ALXO) was $1.83 for the day, down -2.14% from the previous closing price of $1.87. In other words, the price has decreased by -$2.14 from its previous closing price. On the day, 0.55 million shares were traded. ALXO stock price reached its highest trading level at $1.965 during the session, while it also had its lowest trading level at $1.75.
Ratios:
Our analysis of ALXO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on December 19, 2024, Downgraded its rating to Hold and sets its target price to $2 from $12 previously.
On March 08, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also upped its target price recommendation from $10 to $14.
Jefferies Upgraded its Hold to Buy on December 08, 2023, whereas the target price for the stock was revised from $8 to $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’24 when Hemrajani Rekha bought 30,000 shares for $1.55 per share. The transaction valued at 46,404 led to the insider holds 33,000 shares of the business.
Pinto Shelly sold 564 shares of ALXO for $1,455 on Aug 14 ’24. The SVP, FINANCE AND CAO now owns 91,549 shares after completing the transaction at $2.58 per share. On Aug 14 ’24, another insider, Randolph Sophia, who serves as the CHIEF MEDICAL OFFICER of the company, sold 1,365 shares for $2.58 each. As a result, the insider received 3,522 and left with 325,711 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 96519872 and an Enterprise Value of -45772172.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is 21.64%, while the 200-Day Moving Average is calculated to be -70.84%.
Shares Statistics:
ALXO traded an average of 943.40K shares per day over the past three months and 1820730 shares per day over the past ten days. A total of 52.74M shares are outstanding, with a floating share count of 34.33M. Insiders hold about 34.92% of the company’s shares, while institutions hold 58.48% stake in the company. Shares short for ALXO as of 1732838400 were 7171358 with a Short Ratio of 8.90, compared to 1730332800 on 7842727. Therefore, it implies a Short% of Shares Outstanding of 7171358 and a Short% of Float of 23.56.
